Devices & Diagnostics, Health IT

GreatCall, AliveCor make heart monitoring mobile

GreatCall, a mobile health developer of apps, smart phones and other products, and monitoring device […]

GreatCall, a mobile health developer of apps, smart phones and other products, and monitoring device developer AliveCor are merging mobile health with cardiology.

GreatCall will now offer AliveCor’s heart monitor as an accessory on a Touch3 smartphone, allowing consumers with suspected or diagnosed heart conditions to more closely monitor their own cardiac health.

The AliveCor Heart Monitor, which retails for $200, includes medical grade electrocardiogram recordings, which can be shared directly with a physician or cardiologist by way of a cloud-based analysis, according to the company.

Recently, the device was granted FDA clearance for its algorithm that can immediately detect if patients are experiencing atrial fibrillation, the most common form of cardiac arrhythmia.

The monitor is intended to record, store and transfer ECG rhythms. It also displays ECG rhythms and detects the presence of atrial fibrillation when prescribed or used under the care of a physician.

The monitor is geared toward healthcare professionals or patients with known or suspected heart conditions, and is compatible with all iOS models and most Android mobile devices. Users have the ability to access their data confidentially anytime, anywhere.

San Diego-based GreatCall said it can take “as little as 30 minutes” for users to receive reviews for their ECGs, providing a “more complete picture” of a patient’s heart health.

The device fits on the back of a Touch3 smartphone, made by GreatCall. It rests on the user’s fingers or chest to record an EDG and then converts electrical impulses from the user’s fingertips into ultrasound signals. Those signals are then transmitted to the mobile device’s microphone and into the AliveECG app, developed by GreatCall.

With heart disease being the leading cause of death in the U.S., the device, and mobile monitoring for cardiology in general, could help reduce costs significantly while improving access, said David Inns, CEO of GreatCall.

 

Shares0
Shares0